These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15523685)

  • 1. p53 autoantibodies predict subsequent development of cancer.
    Li Y; Karjalainen A; Koskinen H; Hemminki K; Vainio H; Shnaidman M; Ying Z; Pukkala E; Brandt-Rauf PW
    Int J Cancer; 2005 Mar; 114(1):157-60. PubMed ID: 15523685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients.
    Cressey R; Pimpa S; Chewaskulyong B; Lertprasertsuke N; Saeteng S; Tayapiwatana C; Kasinrerk W
    BMC Biotechnol; 2008 Feb; 8():16. PubMed ID: 18284706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum p53 antibodies as early markers of lung cancer.
    Lubin R; Zalcman G; Bouchet L; Trédanel J; Legros Y; Cazals D; Hirsch A; Soussi T
    Nat Med; 1995 Jul; 1(7):701-2. PubMed ID: 7585154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer.
    Oshikawa K; Sugiyama Y
    Respir Med; 2000 Nov; 94(11):1085-91. PubMed ID: 11127496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.
    Angelopoulou K; Rosen B; Stratis M; Yu H; Solomou M; Diamandis EP
    Cancer; 1996 Nov; 78(10):2146-52. PubMed ID: 8918407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
    Lenner P; Wiklund F; Emdin SO; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
    Br J Cancer; 1999 Feb; 79(5-6):927-32. PubMed ID: 10070892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer.
    Teras LR; Gapstur SM; Maliniak ML; Jacobs EJ; Gansler T; Michel A; Pawlita M; Waterboer T; Campbell PT
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):219-223. PubMed ID: 29254936
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations, tissue accumulations, and serum levels of p53 in patients with occupational cancers from asbestos and silica exposure.
    Husgafvel-Pursiainen K; Kannio A; Oksa P; Suitiala T; Koskinen H; Partanen R; Hemminki K; Smith S; Rosenstock-Leibu R; Brandt-Rauf PW
    Environ Mol Mutagen; 1997; 30(2):224-30. PubMed ID: 9329647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance.
    Würl P; Weigmann F; Meye A; Fittkau M; Rose U; Berger D; Rath FW; Dralle H; Taubert H
    Scand J Gastroenterol; 1997 Nov; 32(11):1147-51. PubMed ID: 9399397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of serum p53 antibodies in lung cancer.
    Mattioni M; Soddu S; Prodosmo A; Visca P; Conti S; Alessandrini G; Facciolo F; Strigari L
    BMC Cancer; 2015 Mar; 15():148. PubMed ID: 25884692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum p53 antibody detection in patients with impaired lung function.
    Mattioni M; Chinzari P; Soddu S; Strigari L; Cilenti V; Mastropasqua E
    BMC Cancer; 2013 Feb; 13():62. PubMed ID: 23384026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibody biomarkers in the detection of cancer.
    Cho-Chung YS
    Biochim Biophys Acta; 2006 Jun; 1762(6):587-91. PubMed ID: 16730166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum p53 antibody assay: evaluation in colorectal cancer].
    Hammel P; Soussi T
    Rev Med Interne; 2000 Feb; 21(2):167-73. PubMed ID: 10703073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Autoantibodies Associated with Basal-like Breast Cancers.
    Wang J; Figueroa JD; Wallstrom G; Barker K; Park JG; Demirkan G; Lissowska J; Anderson KS; Qiu J; LaBaer J
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1332-40. PubMed ID: 26070530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 autoantibodies in patients with pancreatitis and pancreatic carcinoma.
    Raedle J; Oremek G; Welker M; Roth WK; Caspary WF; Zeuzem S
    Pancreas; 1996 Oct; 13(3):241-6. PubMed ID: 8884844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer.
    Agaylan A; Binder D; Sauer M; Neuweiler H; Meyer O; Kiesewetter H; Salama A
    Cancer; 2007 Dec; 110(11):2502-6. PubMed ID: 17932907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against P53 protein in patients with transitional cell carcinoma of the bladder.
    Sanchez-Carbayo M; Chulia MT; Niveiro M; Aranda I; Mira A; Soria F
    Anticancer Res; 1999; 19(4C):3531-7. PubMed ID: 10629648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.